Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 13

Results: 16

Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1910, doi. 10.1038/sj.onc.1209979

By:

Habens, F.;
Lapham, A. S.;
Dallman, C. L.;
Pickering, B. M.;
Michels, J.;
Marcusson, E. G.;
Johnson, P. W. M.;
Packham, G.

Publication type:

Article

Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1920, doi. 10.1038/sj.onc.1209981

By:

Lau, L.;
Hansford, L. M.;
Cheng, L. S.;
Hang, M.;
Baruchel, S.;
Kaplan, D. R.;
Irwin, M. S.

Publication type:

Article

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1875, doi. 10.1038/sj.onc.1209984

By:

Cronauer, M. V.;
Ince, Y.;
Engers, R.;
Rinnab, L.;
Weidemann, W.;
Suschek, C. V.;
Burchardt, M.;
Kleinert, H.;
Wiedenmann, J.;
Sies, H.;
Ackermann, R.;
Kröncke, K.-D.

Publication type:

Article

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1959, doi. 10.1038/sj.onc.1209985

By:

Chin, S.-F.;
Wang, Y.;
Thorne, N. P.;
Teschendorff, A. E.;
Pinder, S. E.;
Vias, M.;
Naderi, A.;
Roberts, I.;
Barbosa-Morais, N. L.;
Garcia, M. J.;
Iyer, N. G.;
Kranjac, T.;
Robertson, J. F. R.;
Aparicio, S.;
Tavaré, S.;
Ellis, I.;
Brenton, J. D.;
Caldas, C.

Publication type:

Article

Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1971, doi. 10.1038/sj.onc.1209986

By:

Wong, Y. F.;
Cheung, T. H.;
Lo, K. W. K.;
Yim, S. F.;
Siu, N. S. S.;
Chan, S. C. S.;
Ho, T. W. F.;
Wong, K. W. Y.;
Yu, M. Y.;
Wang, V. W.;
Li, C.;
Gardner, G. J.;
Bonome, T.;
Johnson, W. B.;
Smith, D. I.;
Chung, T. K. H.;
Birrer, M. J.

Publication type:

Article

A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1829, doi. 10.1038/sj.onc.1209987

By:

Bagella, L.;
Sun, A.;
Tonini, T.;
Abbadessa, G.;
Cottone, G.;
Paggi, M. G.;
De Luca, A.;
Claudio, P. P.;
Giordano, A.

Publication type:

Article

p53 downregulates expression of the G1/S cell cycle phosphatase Cdc25A.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1949, doi. 10.1038/sj.onc.1209989

By:

Rother, K.;
Kirschner, R.;
Sänger, K.;
Böhlig, L.;
Mössner, J.;
Engeland, K.

Publication type:

Article

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1932, doi. 10.1038/sj.onc.1209990

By:

Wan, X.;
Harkavy, B.;
Shen, N.;
Grohar, P.;
Helman, L. J.

Publication type:

Article

Tumor suppressor activity of glucocorticoid receptor in the prostate.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1885, doi. 10.1038/sj.onc.1209991

By:

Yemelyanov, A.;
Czwornog, J.;
Chebotaev, D.;
Karseladze, A.;
Kulevitch, E.;
Yang, X.;
Budunova, I.

Publication type:

Article

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1840, doi. 10.1038/sj.onc.1209992

By:

Iwamaru, A.;
Kondo, Y.;
Iwado, E.;
Aoki, H.;
Fujiwara, K.;
Yokoyama, T.;
Mills, G. B.;
Kondo, S.

Publication type:

Article

Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1941, doi. 10.1038/sj.onc.1209993

By:

Evans, M. K.;
Yu, C.-R.;
Lohani, A.;
Mahdi, R. M.;
Liu, X.;
Trzeciak, A. R.;
Egwuagu, C. E.

Publication type:

Article

Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1954, doi. 10.1038/sj.onc.1209994

By:

Liu, J.;
Suresh Kumar, K. G.;
Yu, D.;
Molton, S. A.;
McMahon, M.;
Herlyn, M.;
Thomas-Tikhonenko, A.;
Fuchs, S. Y.

Publication type:

Article

Chromosomes with delayed replication timing lead to checkpoint activation, delayed recruitment of Aurora B and chromosome instability.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1852, doi. 10.1038/sj.onc.1209995

By:

Chang, B. H.;
Smith, L.;
Huang, J.;
Thayer, M.

Publication type:

Article

Snail silencing effectively suppresses tumour growth and invasiveness.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1862, doi. 10.1038/sj.onc.1209997

By:

Olmeda, D.;
Jordá, M.;
Peinado, H.;
Fabra, Á.;
Cano, A.

Publication type:

Article

E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1897, doi. 10.1038/sj.onc.1209998

By:

Crosby, M. E.;
Jacobberger, J.;
Gupta, D.;
Macklis, R. M.;
Almasan, A.

Publication type:

Article

Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.

Published in:

2007

By:

Cerone, M. A.;
Londoño-Vallejo, J. A.;
Autexier, C.

Publication type:

Correction Notice

Works matching IS 09509232 AND DT 2007 AND VI 26 AND IP 13

Distinct promoters mediate constitutive and inducible Bcl-X<sub>L</sub> expression in malignant lymphocytes.

Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma.

Nitric oxide-mediated inhibition of androgen receptor activity: possible implications for prostate cancer progression.

Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers.

Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.

A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo.

p53 downregulates expression of the G<sub>1</sub>/S cell cycle phosphatase Cdc25A.

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

Tumor suppressor activity of glucocorticoid receptor in the prostate.

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.

Expression of SOCS1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.

Oncogenic BRAF regulates β-Trcp expression and NF-κB activity in human melanoma cells.

Chromosomes with delayed replication timing lead to checkpoint activation, delayed recruitment of Aurora B and chromosome instability.

Snail silencing effectively suppresses tumour growth and invasiveness.

E2F4 regulates a stable G<sub>2</sub> arrest response to genotoxic stress in prostate carcinoma.

Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance.